Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. It interacts primarily with the ghrelin (GHS-R1a) receptor and has been studied for its ability to stimulate growth hormone release and for its effects on growth hormone signaling, IGF-1 pathways, metabolism, and endocrine function.
Ipamorelin remains an investigational compound and is not an FDA-approved drug. The FDA has also identified potential safety concerns with compounded ipamorelin products, including peptide aggregation, impurities, and possible immunogenicity.
For Research Use Only. Not for Human Consumption.
This product is intended strictly for laboratory and scientific research purposes and is not intended to diagnose, treat, cure, or prevent any disease.
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. It interacts primarily with the ghrelin (GHS-R1a) receptor and has been studied for its ability to stimulate growth hormone release and for its effects on growth hormone signaling, IGF-1 pathways, metabolism, and endocrine function.
Ipamorelin remains an investigational compound and is not an FDA-approved drug. The FDA has also identified potential safety concerns with compounded ipamorelin products, including peptide aggregation, impurities, and possible immunogenicity.
For Research Use Only. Not for Human Consumption.
This product is intended strictly for laboratory and scientific research purposes and is not intended to diagnose, treat, cure, or prevent any disease.